Foreign
Health Alert : Four India-made cough syrups kills 66 children in The Gambia -WHO
Published
2 years agoon
By
Vida Essel-LampteyA global alert has been issued over four cough syrups after the World Health Organization (WHO) warned they could be linked to the deaths of 66 children in The Gambia.
The syrups have been “potentially linked with acute kidney injuries and 66 deaths among children”, it said.
The products were manufactured by an Indian company, Maiden Pharmaceuticals, which had failed to provide guarantees about their safety, the WHO added.
The firm has not yet commented.
The BBC has contacted Maiden Pharmaceuticals for comment.
The WHO identified the medicines as Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The four products had been identified in The Gambia, but “may have been distributed, through informal markets, to other countries or regions”, the WHO added, in the alert published on its website.
It warned that their use may result in serious injury or death, especially among children.
The WHO’s intervention came after medical authorities in The Gambia – a popular tourist destination – detected an increase in cases of acute kidney injury among children under the age of five in late July.
The Gambia’s government has since suspended the use of all paracetamol syrups and has urged people to use tablets instead.
The WHO said that laboratory analysis of samples of the products “confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.”
The substances were toxic, and their effects “can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state and acute kidney injury which may lead to death,” it added.
The Gambia’s health officials said last month that dozens of children had died, without giving an exact number.
Speaking in Geneva on Wednesday, WHO chief Tedros Ghebreyesus said: “The loss of these young lives is beyond heart-breaking for their families.”
The WHO said that India’s Central Drugs Standard Control Organisation indicated that the manufacturer may have only supplied the contaminated medications to The Gambia, AFP news agency reports, quoting an email from the UN health agency.
But the WHO said that “global exposure” was possible as the “manufacturer may have used the same contaminated material in other products and distributed them locally or exported” them, the agency reports.
Source: BBC
You may like
-
Africa needs real economic transformation – Merck Foundation
-
Inject all of us so we die if you will not help us – Spokesperson for fellows with renal diseases tells gov’t
-
Britney Spears’ third marriage hits the rock, split with husband 14 months on
-
Deadly Mediterranean wildfires kill more than 40
-
Ship with 3,000 cars in deadly fire off Dutch coast
-
Ukraine war: Russian general fired after criticising army leaders
Mahama leads NDC to mourn with Kufuor over wife’s passing
Former President John Dramani Mahama on Wednesday, October 4 led a delegation from the National Democratic Congress (NDC) to visit...
Former First Lady of Ghana Theresa Kufuor reported dead
The former First Lady of Ghana and wife of Ghana’s former President, John Agyekum Kufour, Mrs Theresa Kufuor has been...
The most powerful tool for change is the right to vote – Mahama
The 2024 flagbearer of the National Democratic Congress (NDC), John Dramani Mahama, is rallying Ghanaains who have grown disillusioned with...
PFJ was a mere state resource looting platform – Minority
The Minority has descended heavily on the Akufo-Addo-led government for launching a second phase of the flagship Planting for Food...
ECOWAS is desecrating Ghana
The Director of Legal Affairs of the National Democratic Congress (NDC), Mr Abraham Amaliba has said the Economy Community of...
Prof Gyampo elected President of UTAG, University of Ghana branch
A Senior Lecturer at the Political Science Department of the University of Ghana (Legon), Prof Ransford Gyampo have been elected...